SCLC subtype-enriched biomarkers define positioning of Aurora B inhibitor combination with venetoclax. (October 2020) - Della Corte, C.; Gay, C.; Urosevic, J.; Polanska, U.; Ajpacaja, L.; Wijnhoven, P.; Wang, J.; Coker, E.; Fabbri, G.; Jaaks, P.; Jerome, M.; Cosaert, J.; et al.